ACETYL LEUCINE OR ITS PHARMACEUTICALLY ACCEPTABLE SALT FOR IMPROVING THE MOTOR FUNCTION AND THE COGNITIVE FUNCTION Russian patent published in 2021 - IPC A61K31/198 A61P25/28 

Abstract RU 2745912 C2

FIELD: medicine.

SUBSTANCE: invention relates to the field of medicine and is connected with the use of acetyl leucine or a pharmaceutically acceptable salt thereof for improving an aging-related movement disorder in a subject selected from reduced stability, gait instability, senile gait disorder, increased gait velocity or frequency variation coefficient steps, a tendency to fall. An individual is free from dizziness or any clinically apparent neurological or neurodegenerative disease, disorder, or condition.

EFFECT: invention improves the motor function.

9 cl, 6 dwg, 2 tbl, 12 ex

Similar patents RU2745912C2

Title Year Author Number
THERAPEUTIC AGENTS FOR NEURODEGENERATIVE DISEASES 2018
  • Factor, Mallory
RU2763425C2
THERAPEUTIC AGENTS AGAINST NEURODEGENERATIVE DISEASES 2017
  • Strupp, Michael
RU2756519C2
PHARMACEUTICAL COMPOSITIONS AND APPLICATIONS AGAINST LYSOSOMAL STORAGE DISEASES 2017
  • Shtrup, Mikhael
RU2749515C2
THERAPEUTIC AGENTS FOR THE TREATMENT OF RESTLESS LEG SYNDROME 2019
  • Factor, Mallory
  • Strupp, Michael
RU2802288C2
DEUTERATED ANALOGUES OF ACETYLEUCINE 2019
  • Mann, Michiko
RU2810793C2
COMBINATION OF ACETYLLEICINE FOR TREATMENT OF DIZZINESS 2017
  • Syrov Kirill Konstantinovich
  • Nesteruk Vladimir Viktorovich
  • Zamergrad Maksim Valerevich
RU2680413C1
TREATMENT OF MIGRAINE 2018
  • Strupp, Michael
  • Factor, Mallory
RU2772278C2
LEUCINE, ACETYLLECINE AND RELATED ANALOGUES FOR TREATMENT OF DISEASE 2020
  • Factor, Mallory
  • Fields, Taylor
RU2815373C2
DPP-IV INHIBITORS FOR TREATMENT OF NEURODEGENERATION AND COGNITIVE DISORDERS 2005
  • Kh'Juz Tomas Ehduard
RU2394570C2
NEUROPROTECTIVE AND RETINOPROTECTIVE AGENT N-ACETYL-DL-LEUCINE 2011
  • Rekik Rauf
RU2598339C2

RU 2 745 912 C2

Authors

Fektor, Mellori

Shtrup, Mikhael

Dates

2021-04-02Published

2017-04-19Filed